Arturo Cirera de Tudela

Arturo Cirera de Tudela

Auto-generated profile, based on publicly available information

Arturo Cirera de Tudela

Colorectal Surgery, Department of General and Digestive Surgery, Vall d’Hebron University Hospital, 08035 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
ERElizabeth Pando Rau
Elizabeth Pando Rau
PAPiero Alberti
Piero Alberti
RMRodrigo Mata
Rodrigo Mata
MGMaría José Gomez
María José Gomez
LVLaura Vidal
Laura Vidal
RCRamon Charco
Ramon Charco
Background. Changes in BUN have been proposed as a risk factor for complications in acute pancreatitis (AP). Our study aimed to compare changes in BUN versus the Bedside Index for Severity in Acute Pancreatitis (BISAP) score and the Acute Physiology and Chronic Health Evaluation‐II score (APACHE‐II), as well as other laboratory tests such as haematocrit and its variations over 24 h and C‐reactive protein, in order to determine the most accurate test for predicting mortality and severity outcomes in AP. Methods. Clinical data of 410 AP patients, prospectively enrolled for study at our institution, were analyzed. We define AP according to Atlanta classification (AC) 2012. The laboratory test’s predictive accuracy was measured using area‐under‐the‐curve receiver‐operating characteristics (AUC) analysis and sensitivity and specificity tests. Results. Rise in BUN was the only score related to mortality on the multivariate analysis (p = 0.000, OR: 12.7; CI 95%: 4.2−16.6). On the comparative analysis of AUC, the rise in BUN was an accurate test in predicting mortality (AUC: 0.842) and persisting multiorgan failure (AUC: 0.828), similar to the BISAP score (AUC: 0.836 and 0.850) and APACHE‐II (AUC: 0.756 and 0.741). The BISAP score outperformed both APACHE‐II and rise in BUN at 24 hours in predicting severe AP (AUC: 0.873 vs. 0.761 and 0.756, respectively). Conclusion. Rise in BUN at 24 hours is a quick and reliable test in predicting mortality and persisting multiorgan failure in AP patients.

1 June 2022 in HPB
Verified
Journal Article
Closed access
PAPiero Alberti
Piero Alberti
ERElizabeth Pando Rau
Elizabeth Pando Rau
RMRodrigo Mata
Rodrigo Mata
ACArturo Cirera
Arturo Cirera
NFNair Fernandes
Nair Fernandes
RCRamón Charco
Ramón Charco

17 May 2021 in Medicina
Verified
Journal Article
Open access
PDF file
Ramon VilallongaRamon Vilallonga
Ramon Vilallonga
SSSergio Sanchez-Cordero
Sergio Sanchez-Cordero
Nicolas Umpiérrez MayorNicolas Umpiérrez Mayor
Nicolas Umpiérrez Mayor
AMAlicia Molina
Alicia Molina
ATArturo Cirera de Tudela
Arturo Cirera de Tudela
MCManel Armengol Carrasco
Manel Armengol Carrasco
Background and Objectives: Bariatric surgery remains the gold standard treatment for morbidly obese patients. Roux-en-y gastric bypass and laparoscopic sleeve gastrectomy are the most frequently performed surgeries worldwide. Obesity has also been related to gastroesophageal reflux disease (GERD). The management of a preoperative diagnosis of GERD, with/without hiatal hernia before bariatric surgery, is mandatory. Endoscopy can show abnormal findings that might influence the final type of surgery. The aim of this article is to discuss and review the evidence related to the endoscopic findings after bariatric surgery. Materials and Methods: A systematic review of the literature has been conducted, including all recent articles related to endoscopic findings after bariatric surgery. Our review of the literature has included 140 articles, of which, after final review, only eight were included. The polled articles included discussion of the endoscopy findings after roux-en-y gastric bypass and laparoscopic sleeve gastrectomy. Results: We found that the specific care of bariatric patients might include an endoscopic diagnosis when GERD symptoms are present. Conclusions: Recent evidence has shown that endoscopic follow-up after laparoscopic sleeve gastrectomy could be advisable, due to the pathological findings in endoscopic procedures in asymptomatic patients.

5 March 2025 in Techniques in Coloproctology
Verified
Journal Article
Open access
PDF file
IMI. Maya
I. Maya
ESE. Spada
E. Spada
MMMarc Martí
Marc Martí
ATA. Cirera de Tudela
A. Cirera de Tudela
Gianluca PellinoGianluca Pellino
Gianluca Pellino
EBEloy Espin Basany
Eloy Espin Basany
Background Treating complex anal fistulae (CAF) remains a clinical challenge. Regenerative fistula treatment (RFT) with a bioactive matrix enriched with autologous platelet concentrate (Obsidian RFT®) has shown potential in healing CAF while preserving continence, but its long-term efficacy is still debated. This study aims to report the outcomes of RFT in patients with CAF. Methods A retrospective analysis of a prospective database of patients with CAF treated with RFT between February 2021 and November 2023 at a single center was conducted. Patients were included if they completed at least a 6-month follow-up. The primary outcome was fistula healing at last available follow-up. Secondary outcomes included unscheduled reoperation and anorectal function. Results A total of 31 patients were treated with Obsidian RFT, 17 of whom completed the 6-month follow-up. Nine of the patients were women. The median age was 47 (24–63) years, and eight had inflammatory bowel disease. High transsphincteric fistulae were observed in 52.9% of patients. At a median follow-up of 21.8 (8–36) months, a 53% success rate was achieved. Approximately half of patients required at least one additional procedure owing to CAF persistence or recurrence. There were no reports of morbidity or mortality, and no worsening of continence was observed. Conclusions This pilot study demonstrated that nearly half of the patients treated with RFT for CAF achieved long-term healing, with no adverse effects on continence and an excellent safety profile. Larger studies are needed to draw definitive conclusions.

4 May 2022 in Colorectal Disease
Verified
Journal Article
Open access
ASAlejandro Solís‐Peña
Alejandro Solís‐Peña
ACArturo Cirera
Arturo Cirera
MKMiquel Kraft
Miquel Kraft
Gianluca PellinoGianluca Pellino
Gianluca Pellino
EBEloy Espin Basany
Eloy Espin Basany
Aim Intracorporeal anastomosis has been associated with earlier recovery of postoperative bowel function, shorter length of stay and lower surgical site infection rates. The aim of this work is to describe a step-by-step standardized technique for intracorporeal ileocolic and ileosigmoid anastomosis suitable for laparoscopic and robotic colectomy. Method Each step of the technique is illustrated using a composite collection of three operative patient videos. Two procedures were performed robotically and one was laparoscopic. Tips are provided to construct a two-layer anastomosis (both posteriorly and anteriorly). The procedures are presented in stepwise fashion, discussing the advantages and feasibility of the technique. Results The standardized technique described herein was used in three patients for this report, of whom two underwent right colectomy and one subtotal colectomy for cancer. The median operating time was 255 (206-333) min. There were no intraoperative complications. No major postoperative complications or 30-day readmissions occurred. The median length of stay was 4 (3-5) days. Conclusion The described technique of a two-layer anastomosis can be used with any available minimally invasive approach. It is safe and feasible. Using a standardized approach, the technique can be easily taught and mastered, optimizing operating times and reducing adverse events.

14 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CNClemente Junior Nappi
Clemente Junior Nappi
ATArturo Cirera de Tudela
Arturo Cirera de Tudela
MMMarc Martí
Marc Martí
MKMiquel Kraft
Miquel Kraft
JPJosé Perea
José Perea
EBEloy Espin Basany
Eloy Espin Basany
Background: The incidence of early-onset colorectal cancer (EOCRC) has increased worldwide and now represents approximately 10% of colorectal cancers in high-income countries. EOCRC is frequently associated with advanced pathological features, although its clinical behavior and optimal management remain incompletely defined. Methods: We performed a retrospective single-center study including 88 consecutive patients aged ≤50 years who underwent curative-intent colorectal cancer resection between January 2019 and December 2023 at a tertiary referral center. Perioperative outcomes, pathological characteristics, and recurrence patterns were analyzed. Results: The median age was 44 years, and 67% of tumors were located in the colon. Pathological nodal involvement (pN+) was observed in 47.7% of patients, with a high prevalence of adverse features including perineural invasion (62.5%), tumor budding (17.0%), and tumor deposits (15.9%). Minimally invasive surgery was performed in 79% of patients and was associated with shorter hospital stay without increased postoperative morbidity (19.3%). During a median follow-up of 31.3 months [IQR 21.6–44.6], recurrence occurred in 40 patients (45.5%) and was predominantly distant (75.0%). Among patients with recurrence, 21 (52.5%) underwent surgical reintervention, most commonly hepatic and pulmonary resections. Rectal cancer was associated with higher rates of stoma formation and major postoperative complications compared to colon cancer. Conclusions: EOCRC is characterized by a high prevalence of adverse pathological features and a substantial rate of distant recurrence. However, a relevant proportion of recurrences remains amenable to surgical treatment in selected patients. Management in a specialized tertiary center allows achievement of high-quality surgical outcomes and supports an aggressive multidisciplinary approach.